Found: 46
Select item for more details and to access through your institution.
A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens.
- Published in:
- International Journal of Oncology, 2015, v. 46, n. 1, p. 55, doi. 10.3892/ijo.2014.2699
- By:
- Publication type:
- Article
A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients with HCV with various HLA class IA alleles.
- Published in:
- Journal of Medical Virology, 2009, v. 81, n. 7, p. 1232, doi. 10.1002/jmv.21518
- By:
- Publication type:
- Article
Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b<sup>+</sup> HLA-A24<sup>+</sup> patients
- Published in:
- Hepatology Research, 2005, v. 32, n. 4, p. 227, doi. 10.1016/j.hepres.2005.06.003
- By:
- Publication type:
- Article
Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Human dermal fibroblast migration induced by fibronectin in autocrine and paracrine manners.
- Published in:
- Experimental Dermatology, 2014, v. 23, n. 9, p. 682, doi. 10.1111/exd.12447
- By:
- Publication type:
- Article
Humoral Immune Responses to EGFR-Derived Peptides Predict Progression-Free and Overall Survival of Non-Small Cell Lung Cancer Patients Receiving Gefitinib.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086667
- By:
- Publication type:
- Article
EGFR T790M Mutation as a Possible Target for Immunotherapy; Identification of HLA-A*0201-Restricted T Cell Epitopes Derived from the EGFR T790M Mutation.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0078389
- By:
- Publication type:
- Article
Identification of Special AT-Rich Sequence Binding Protein 1 as a Novel Tumor Antigen Recognized by CD8<sup>+</sup> T Cells: Implication for Cancer Immunotherapy.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056730
- By:
- Publication type:
- Article
Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8<sup>+</sup> T Cells for Cancer Immunotherapy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045756
- By:
- Publication type:
- Article
Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2013, v. 2013, p. 1, doi. 10.1155/2013/981717
- By:
- Publication type:
- Article
Recent clinical researches and technological development in TIL therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03793-4
- By:
- Publication type:
- Article
Successful ex vivo expansion of tumor infiltrating lymphocytes with systemic chemotherapy prior to surgical resection.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3377, doi. 10.1007/s00262-023-03500-9
- By:
- Publication type:
- Article
A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 151, doi. 10.1007/s00262-015-1781-6
- By:
- Publication type:
- Article
Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 493, doi. 10.1007/s00262-015-1660-1
- By:
- Publication type:
- Article
Breast cancer cells expressing stem cell markers CD44<sup>+</sup> CD24<sup>lo</sup> are eliminated by Numb-1 peptide-activated T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1185, doi. 10.1007/s00262-008-0623-1
- By:
- Publication type:
- Article
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1359, doi. 10.1007/s00262-007-0284-5
- By:
- Publication type:
- Article
Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 689, doi. 10.1007/s00262-006-0216-9
- By:
- Publication type:
- Article
Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2<sup>+</sup> patients with hormone-refractory prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 6, p. 479, doi. 10.1007/s00262-003-0464-x
- By:
- Publication type:
- Article
Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor Tissue.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2536, doi. 10.3390/cancers15092536
- By:
- Publication type:
- Article
Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females.
- Published in:
- Experimental & Therapeutic Medicine, 2017, v. 13, n. 4, p. 1500, doi. 10.3892/etm.2017.4150
- By:
- Publication type:
- Article
The Global Influence of the Madden-Julian Oscillation on Extreme Temperature Events*.
- Published in:
- Journal of Climate, 2015, v. 28, n. 10, p. 4141, doi. 10.1175/JCLI-D-14-00625.1
- By:
- Publication type:
- Article
Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy.
- Published in:
- Prostate, 2012, v. 72, n. 8, p. 834, doi. 10.1002/pros.21485
- By:
- Publication type:
- Article
New epitope peptides derived from parathyroid hormone-related protein which have the capacity to induce prostate cancer-reactive cytotoxic T lymphocytes in HLA-A2+ prostate cancer patients.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 233, doi. 10.1002/pros.20133
- By:
- Publication type:
- Article
Identification of polycomb group protein enhancer of zeste homolog 2 (EZH2)‐derived peptides immunogenic in HLA‐A24+ prostate cancer patients.
- Published in:
- Prostate, 2004, v. 60, n. 4, p. 273, doi. 10.1002/pros.20078
- By:
- Publication type:
- Article
Prostate-specific antigen-derived epitopes capable of inducing cellular and humoral responses in HLA-A24<sup>+</sup> prostate cancer patients.
- Published in:
- Prostate, 2003, v. 57, n. 2, p. 152, doi. 10.1002/pros.10280
- By:
- Publication type:
- Article
Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients.
- Published in:
- International Journal of Oncology, 2020, v. 56, n. 6, p. 1479, doi. 10.3892/ijo.2020.5019
- By:
- Publication type:
- Article
Exploring the Potential of Humoral Immune Response to Commensal Bifidobacterium as a Biomarker for Human Health, including Both Malignant and Non-Malignant Diseases: A Perspective on Detection Strategies and Future Directions.
- Published in:
- Biomedicines, 2024, v. 12, n. 4, p. 803, doi. 10.3390/biomedicines12040803
- By:
- Publication type:
- Article
Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 12, p. 3208, doi. 10.1002/cncr.26636
- By:
- Publication type:
- Article
Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides.
- Published in:
- Virology Journal, 2012, v. 9, n. 1, p. 199, doi. 10.1186/1743-422X-9-199
- By:
- Publication type:
- Article
Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte‐specific protein tyrosine kinase.
- Published in:
- Cancer Science, 2018, v. 109, n. 3, p. 611, doi. 10.1111/cas.13522
- By:
- Publication type:
- Article
Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies.
- Published in:
- Cancer Science, 2017, v. 108, n. 9, p. 1732, doi. 10.1111/cas.13301
- By:
- Publication type:
- Article
A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer.
- Published in:
- Cancer Science, 2017, v. 108, n. 5, p. 838, doi. 10.1111/cas.13193
- By:
- Publication type:
- Article
Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11<sup>+</sup> or -A33<sup>+</sup> allele.
- Published in:
- Cancer Science, 2017, v. 108, n. 4, p. 598, doi. 10.1111/cas.13189
- By:
- Publication type:
- Article
Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients.
- Published in:
- Cancer Science, 2016, v. 107, n. 5, p. 590, doi. 10.1111/cas.12919
- By:
- Publication type:
- Article
Identification of novel Lck-derived T helper epitope long peptides applicable for HLA-A<sup>2+</sup> cancer patients as cancer vaccine.
- Published in:
- Cancer Science, 2015, v. 106, n. 11, p. 1493, doi. 10.1111/cas.12805
- By:
- Publication type:
- Article
Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele.
- Published in:
- Cancer Science, 2015, v. 106, n. 10, p. 1257, doi. 10.1111/cas.12757
- By:
- Publication type:
- Article
Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy.
- Published in:
- Cancer Science, 2015, v. 106, n. 9, p. 1111, doi. 10.1111/cas.12729
- By:
- Publication type:
- Article
PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer.
- Published in:
- Cancer Science, 2014, v. 105, n. 10, p. 1229, doi. 10.1111/cas.12502
- By:
- Publication type:
- Article
Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients.
- Published in:
- Cancer Science, 2013, v. 104, n. 10, p. 1285, doi. 10.1111/cas.12226
- By:
- Publication type:
- Article
Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer.
- Published in:
- Cancer Science, 2012, v. 103, n. 4, p. 638, doi. 10.1111/j.1349-7006.2012.02202.x
- By:
- Publication type:
- Article
Japan Meteorological Agency/Meteorological Research Institute-Coupled Prediction System version 2 (JMA/MRI-CPS2): atmosphere–land–ocean–sea ice coupled prediction system for operational seasonal forecasting.
- Published in:
- Climate Dynamics, 2018, v. 50, n. 3/4, p. 751, doi. 10.1007/s00382-017-3638-5
- By:
- Publication type:
- Article
IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides.
- Published in:
- Oncology Reports, 2018, v. 39, n. 5, p. 2385, doi. 10.3892/or.2018.6288
- By:
- Publication type:
- Article
Effects of corticosteroids and hyaluronic acid on torn rotator cuff tendons in vitro and in rats.
- Published in:
- Journal of Orthopaedic Research, 2015, v. 33, n. 10, p. 1523, doi. 10.1002/jor.22921
- By:
- Publication type:
- Article